Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…lunteers. Animal experiments related to CAR-NK cell therapy for hepatocellular carcinoma were approved by the Institutional Animal Care and Use Committe…
…Background The application of T and NK-cell therapies to solid tumors remains a challenge due to the limited repertoire of suitable t…
…ights the need for safer and more effective CAR T therapies for solid tumors. We previously developed SynKIR-110, a multi-chain CAR T target…
…ns These collective data support the development of AB-3028 for mCRPC.…
…tionality from PBLs, as potential alternative to TIL therapy of solid tumors, especially in the particularly challenging group of patients w…
…(TCR-T cells) has shown promising clinical efficacy in treating solid tumors. Clinical responses in solid tumors may require transfer of ten…
…Background PD-1 blockade therapy revolutionized treatment of solid tumors, but response and eligibility rates remain low. Bispecific anti…
…dult subjects with histologically confirmed relapsed/refractory solid tumors for which no standard treatment options are available, specific…
…ed.Results From 6/2024 to 3/2025, 31 patients were enrolled (26 non-small cell lung cancer, 4 breast cancer, and 1 small cell lung cancer). At the initial…
…egy to overcome key limitations of CD3-directed bsAb therapy in solid tumors.Ethics Approval The study was approved by the IRB (Ethics Commi…
…(Tregs) within the tumor microenvironment (TME) across multiple solid tumors, including breast, colon, and lung cancers. CCR8+ Tregs contrib…
…nd enable downstream activation of adaptive immune responses in solid tumors.Methods IMANs were generated via a proprietary, GMP-compliant d…